Sudha, T.; Godugu, K.; Glinsky, G.V.; Mousa, S.A.
RETRACTED: Sudha et al. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin αvβ3 Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic Cancer. Biomedicines 2022, 10, 795. Biomedicines 2025, 13, 2641.
https://doi.org/10.3390/biomedicines13112641
AMA Style
Sudha T, Godugu K, Glinsky GV, Mousa SA.
RETRACTED: Sudha et al. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin αvβ3 Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic Cancer. Biomedicines 2022, 10, 795. Biomedicines. 2025; 13(11):2641.
https://doi.org/10.3390/biomedicines13112641
Chicago/Turabian Style
Sudha, Thangirala, Kavitha Godugu, Gennadi V. Glinsky, and Shaker A. Mousa.
2025. "RETRACTED: Sudha et al. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin αvβ3 Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic Cancer. Biomedicines 2022, 10, 795" Biomedicines 13, no. 11: 2641.
https://doi.org/10.3390/biomedicines13112641
APA Style
Sudha, T., Godugu, K., Glinsky, G. V., & Mousa, S. A.
(2025). RETRACTED: Sudha et al. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin αvβ3 Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic Cancer. Biomedicines 2022, 10, 795. Biomedicines, 13(11), 2641.
https://doi.org/10.3390/biomedicines13112641
